Awardee OrganizationINDIANA UNIVERSITY INDIANAPOLIS
Description
Abstract Text
Project Summary/Abstract
Binge drinking is a major contributor to the harms of alcohol use disorder (AUD), with high-intensity binge
intake being particularly hazardous. However, little is known about the mechanism(s) that drive front-loading
(strong initial intake rate) and sustained high drinking. Component 1 human results show that familial
history/density of AUD relates to shorter time to reach binge levels, suggestive a heritable risk for excessive
intake, but there is critical unmet need to understand mechanism(s) that drive excessive drinking. To
discover critical brain circuits that drive excessive intake with heritable risk, we use rat lines selected for high
alcohol consumption, P and HAD rats, which may model heritable AUD risk, and moderate-drinking Wistar rats
as controls. Importantly, P rats show greater behavioral responses involving stimulus salience and vigor, while
HAD rats have higher anxiety. Thus, these two lines may model reward versus relief drinking in AUD.
Excessive drinking is likely driven by the strong, salient motivational properties of alcohol, which implicates the
brain’s salience network (SN) which identifies and rapidly responds to important events. We focus on anterior
insula (aINS), a critical regulator of SN and many aspects of motivation- and emotion-driven behavior. Also,
aINS inhibition reduces rodent alcohol drinking, and human studies implicate aINS in both cue- and negative
affect-driven drive for alcohol. However, little is known about specific mechanism(s) whereby aINS
promotes front-loading and sustained high drinking. We specifically examine aINS projections to Nucleus
Accumbens core (NAcb) and Basolateral Amygdala (BLA), since NAcb has widely been linked to vigor and
reward-directed action, with BLA implicated in anxiety expression. Thus, we hypothesize that P rat drinking will
involve greater aINS-NAcb neuronal firing during drinking and greater reduction of consumption when inhibiting
aINS-NAcb (vs HAD and Wistar rats). In contrast, HADs will have higher aINS-BLA encoding of drinking and
greater reduction of intake when inhibiting aINS-BLA. Aim 1 looks for rat line differences in the anatomical size
of aINS-NAcb and aINS-BLA projections. Aim 2 uses cutting edge in vivo neuronal recording to discover firing
patterns during front-loading in aINS-NAcb and aINS-BLA neurons (identified by “opto-tagging,” light-based
stimulation to identify particular cells). We predict that greater aINS firing will correlate with higher front-loading,
especially aINS-BLA in HAD and aINS-NAcore in P rat. Before alcohol, we also examine aINS activity during
anxiety, sedation, and sucrose exposure, to determine whether aINS encoding of these states predicts
excessive intake level. Aim 3 uses projection-specific inhibition methods to specifically suppress aINS-NAcore
or aINS-BLA and test the hypothesis that excessive alcohol intake is more affected by aINS-NAcore inhibition
in P rats and aINS-BLA inhibition in HADs. Together, proposed studies have strong interactions and synergy
with other Components, and, if successful, the positive impact of our work will be the discovery of key aINS
mechanisms that drive front-loading and sustained high alcohol drinking, which would improve AUD treatment.
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
DUNS Number
603007902
UEI
SHHBRBAPSM35
DKNHLK3NBPH7
DL9MTNNKWYR9
GY8GKRUWM7D5
HA48EWMJFV47
HCNBFNDANNV5
HCRDU7BNPZ13
HCWTYJ7KQ4U6
HEBLAL94JHP7
NKCRSKVJBXE3
TA1NYNZ27LQ7
WJJRCLJ936C8
X51WYC1QEPD7
XNBJV454V2W1
YCJNP5NJYCY1
YW8WNKKANDR9
625168166
N/A
Project Start Date
01-December-1989
Project End Date
30-November-2027
Budget Start Date
01-December-2023
Budget End Date
30-November-2024
Project Funding Information for 2024
Total Funding
$216,544
Direct Costs
$137,468
Indirect Costs
$79,076
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$216,544
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P60AA007611-37 5226
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P60AA007611-37 5226
Patents
No Patents information available for 5P60AA007611-37 5226
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P60AA007611-37 5226
Clinical Studies
No Clinical Studies information available for 5P60AA007611-37 5226
News and More
Related News Releases
No news release information available for 5P60AA007611-37 5226
History
No Historical information available for 5P60AA007611-37 5226
Similar Projects
No Similar Projects information available for 5P60AA007611-37 5226